Scientists launch deep dive into rare sarcomas to unlock immune secrets
NCT ID NCT03967834
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is collecting tumor and blood samples from 400 people with rare soft tissue sarcomas to learn how their immune system reacts to the cancer. Researchers will also track patients' health over time to see how the disease progresses. The goal is to find clues that could lead to better treatments in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could help doctors better understand rare sarcomas and point toward new immune-based treatments for these cancers.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly benefit participants, and the findings may not lead to new therapies for years, if at all.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALVEOLAR SOFT PART SARCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Antoine Lacassagne
RECRUITINGNice, 06189, France
-
Centre Eugene Marquis
RECRUITINGRennes, France
-
Centre Georges François Leclerc
NOT_YET_RECRUITINGDijon, France
-
Centre Jean Perrin
RECRUITINGClermont-Ferrand, 63011, France
-
Centre Leon Berard
RECRUITINGLyon, 69008, France
-
Centre Oscar Lambret
RECRUITINGLille, 59020, France
-
Chu Besancon - Site Jean Minjoz
RECRUITINGBesançon, 25000, France
-
Chu Dupuytren
RECRUITINGLimoges, France
-
Chu Poitiers
RECRUITINGPoitiers, France
-
Chu de Marseille - Hopital de La Timone
RECRUITINGMarseille, France
-
Hôpital Cochin - Site Port-Royal
RECRUITINGParis, France
-
Hôpitaux Universitaires de Strasbourg
RECRUITINGStrasbourg, France
-
Institut Bergonié
RECRUITINGBordeaux, France
-
Institut Curie
RECRUITINGParis, France
-
Institut Godinot
RECRUITINGReims, France
-
Institut Gustave Roussy
WITHDRAWNVillejuif, 94805, France
-
Institut Paoli-Calmettes
WITHDRAWNMarseille, 13009, France
-
Institut Universitaire du Cancer Toulouse - Oncopole
RECRUITINGToulouse, France
-
Institut de Cancerologie de L'Ouest - Site Rene Gauducheau
WITHDRAWNSaint-Herblain, 44805, France
-
Institut de Cancerologie de Lorraine
RECRUITINGVandœuvre-lès-Nancy, 54519, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive antibody light up hidden tumors?
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Can a new immunotherapy combo shrink Hard-to-Treat tumors?
- Could a massive tissue bank unlock sarcoma's secrets?
- Can a new drug shrink Hard-to-Treat childhood cancers?
- Can a targeted pill stall advanced sarcomas?